Global Incretin-Based Drugs Market Growth 2018-2023

Publisher Name :
Date: 22-Oct-2018
No. of pages: 130

Incretins are gut derived hormones, released after the ingestion of food. Incretins are classified into glucagon-like peptide-1 (GLP-1) and gastric inhibitory peptide (GIP). Both the molecules are inactivated by enzyme Dipeptidyl Peptidase-4 (DPP-4).

Oral traditional anti-diabetic drugs, often fail to maintain the desired normal level of glucose, especially in the postprandial condition.

This has resulted in a strong need for better therapeutics such as incretin based drugs.

Incretin not only increases the secretion of insulin by acting on pancreatic beta cells, but also inhibits the release of glucagon by acting on the pancreatic alpha cells.

Over the next five years, LPI(LP Information) projects that Incretin-Based Drugs will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.

In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Incretin-Based Drugs market for 2018-2023.

This report presents a comprehensive overview, market shares, and growth opportunities of Incretin-Based Drugs market by product type, application, key manufacturers and key regions.

To calculate the market size, LP Information considers value and volume generated from the sales of the following segments:

Segmentation by product type:

- Glucagon-like peptide-1 receptor (GLP-1) agonists

- Dipeptidyl Peptidase-4 (DPP-4) inhibitors

Segmentation by application:

- Oral Drugs

- Injectable Drugs

This report also splits the market by region:

- Americas

- - United States

- - Canada

- - Mexico

- - Brazil

- APAC

- - China

- - Japan

- - Korea

- - Southeast Asia

- - India

- - Australia

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- - Spain

- Middle East & Africa

- - Egypt

- - South Africa

- - Israel

- - Turkey

- - GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report:

- GlaxoSmithKline

- Johnson & Johnson

- Merck & Co

- AstraZeneca

- Novartis

- Eli Lilly and Company

- Boehringer Ingelheim

- Takeda Pharmaceutical Company

- Sanofi

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

- To study and analyze the global Incretin-Based Drugs consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.

- To understand the structure of Incretin-Based Drugs market by identifying its various subsegments.

- Focuses on the key global Incretin-Based Drugs manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.

- To analyze the Incretin-Based Drugs with respect to individual growth trends, future prospects, and their contribution to the total market.

- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

- To project the consumption of Incretin-Based Drugs submarkets, with respect to key regions (along with their respective key countries).

- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

- To strategically profile the key players and comprehensively analyze their growth strategies.

Global Incretin-Based Drugs Market Growth 2018-2023

Table of Contents

2018-2023 Global Incretin-Based Drugs Consumption Market Report

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Incretin-Based Drugs Consumption 2013-2023
2.1.2 Incretin-Based Drugs Consumption CAGR by Region
2.2 Incretin-Based Drugs Segment by Type
2.2.1 Glucagon-like peptide-1 receptor (GLP-1) agonists
2.2.2 Dipeptidyl Peptidase-4 (DPP-4) inhibitors
2.3 Incretin-Based Drugs Consumption by Type
2.3.1 Global Incretin-Based Drugs Consumption Market Share by Type (2013-2018)
2.3.2 Global Incretin-Based Drugs Revenue and Market Share by Type (2013-2018)
2.3.3 Global Incretin-Based Drugs Sale Price by Type (2013-2018)
2.4 Incretin-Based Drugs Segment by Application
2.4.1 Oral Drugs
2.4.2 Injectable Drugs
2.5 Incretin-Based Drugs Consumption by Application
2.5.1 Global Incretin-Based Drugs Consumption Market Share by Application (2013-2018)
2.5.2 Global Incretin-Based Drugs Value and Market Share by Application (2013-2018)
2.5.3 Global Incretin-Based Drugs Sale Price by Application (2013-2018)

3 Global Incretin-Based Drugs by Players
3.1 Global Incretin-Based Drugs Sales Market Share by Players
3.1.1 Global Incretin-Based Drugs Sales by Players (2016-2018)
3.1.2 Global Incretin-Based Drugs Sales Market Share by Players (2016-2018)
3.2 Global Incretin-Based Drugs Revenue Market Share by Players
3.2.1 Global Incretin-Based Drugs Revenue by Players (2016-2018)
3.2.2 Global Incretin-Based Drugs Revenue Market Share by Players (2016-2018)
3.3 Global Incretin-Based Drugs Sale Price by Players
3.4 Global Incretin-Based Drugs Manufacturing Base Distribution, Sales Area, Product Types by Players
3.4.1 Global Incretin-Based Drugs Manufacturing Base Distribution and Sales Area by Players
3.4.2 Players Incretin-Based Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Incretin-Based Drugs by Regions
4.1 Incretin-Based Drugs by Regions
4.1.1 Global Incretin-Based Drugs Consumption by Regions
4.1.2 Global Incretin-Based Drugs Value by Regions
4.2 Americas Incretin-Based Drugs Consumption Growth
4.3 APAC Incretin-Based Drugs Consumption Growth
4.4 Europe Incretin-Based Drugs Consumption Growth
4.5 Middle East & Africa Incretin-Based Drugs Consumption Growth

5 Americas
5.1 Americas Incretin-Based Drugs Consumption by Countries
5.1.1 Americas Incretin-Based Drugs Consumption by Countries (2013-2018)
5.1.2 Americas Incretin-Based Drugs Value by Countries (2013-2018)
5.2 Americas Incretin-Based Drugs Consumption by Type
5.3 Americas Incretin-Based Drugs Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC Incretin-Based Drugs Consumption by Countries
6.1.1 APAC Incretin-Based Drugs Consumption by Countries (2013-2018)
6.1.2 APAC Incretin-Based Drugs Value by Countries (2013-2018)
6.2 APAC Incretin-Based Drugs Consumption by Type
6.3 APAC Incretin-Based Drugs Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 Europe
7.1 Europe Incretin-Based Drugs by Countries
7.1.1 Europe Incretin-Based Drugs Consumption by Countries (2013-2018)
7.1.2 Europe Incretin-Based Drugs Value by Countries (2013-2018)
7.2 Europe Incretin-Based Drugs Consumption by Type
7.3 Europe Incretin-Based Drugs Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa Incretin-Based Drugs by Countries
8.1.1 Middle East & Africa Incretin-Based Drugs Consumption by Countries (2013-2018)
8.1.2 Middle East & Africa Incretin-Based Drugs Value by Countries (2013-2018)
8.2 Middle East & Africa Incretin-Based Drugs Consumption by Type
8.3 Middle East & Africa Incretin-Based Drugs Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.2 Incretin-Based Drugs Distributors
10.3 Incretin-Based Drugs Customer

11 Global Incretin-Based Drugs Market Forecast
11.1 Global Incretin-Based Drugs Consumption Forecast (2018-2023)
11.2 Global Incretin-Based Drugs Forecast by Regions
11.2.1 Global Incretin-Based Drugs Forecast by Regions (2018-2023)
11.2.2 Global Incretin-Based Drugs Value Forecast by Regions (2018-2023)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Incretin-Based Drugs Forecast by Type
11.8 Global Incretin-Based Drugs Forecast by Application

12 Key Players Analysis
12.1 GlaxoSmithKline
12.1.1 Company Details
12.1.2 Incretin-Based Drugs Product Offered
12.1.3 GlaxoSmithKline Incretin-Based Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
12.1.4 Main Business Overview
12.1.5 GlaxoSmithKline News
12.2 Johnson & Johnson
12.2.1 Company Details
12.2.2 Incretin-Based Drugs Product Offered
12.2.3 Johnson & Johnson Incretin-Based Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
12.2.4 Main Business Overview
12.2.5 Johnson & Johnson News
12.3 Merck & Co
12.3.1 Company Details
12.3.2 Incretin-Based Drugs Product Offered
12.3.3 Merck & Co Incretin-Based Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
12.3.4 Main Business Overview
12.3.5 Merck & Co News
12.4 AstraZeneca
12.4.1 Company Details
12.4.2 Incretin-Based Drugs Product Offered
12.4.3 AstraZeneca Incretin-Based Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
12.4.4 Main Business Overview
12.4.5 AstraZeneca News
12.5 Novartis
12.5.1 Company Details
12.5.2 Incretin-Based Drugs Product Offered
12.5.3 Novartis Incretin-Based Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
12.5.4 Main Business Overview
12.5.5 Novartis News
12.6 Eli Lilly and Company
12.6.1 Company Details
12.6.2 Incretin-Based Drugs Product Offered
12.6.3 Eli Lilly and Company Incretin-Based Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
12.6.4 Main Business Overview
12.6.5 Eli Lilly and Company News
12.7 Boehringer Ingelheim
12.7.1 Company Details
12.7.2 Incretin-Based Drugs Product Offered
12.7.3 Boehringer Ingelheim Incretin-Based Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
12.7.4 Main Business Overview
12.7.5 Boehringer Ingelheim News
12.8 Takeda Pharmaceutical Company
12.8.1 Company Details
12.8.2 Incretin-Based Drugs Product Offered
12.8.3 Takeda Pharmaceutical Company Incretin-Based Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
12.8.4 Main Business Overview
12.8.5 Takeda Pharmaceutical Company News
12.9 Sanofi
12.9.1 Company Details
12.9.2 Incretin-Based Drugs Product Offered
12.9.3 Sanofi Incretin-Based Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
12.9.4 Main Business Overview
12.9.5 Sanofi News

13 Research Findings and Conclusion

List of Tables and Figures

Figure Picture of Incretin-Based Drugs
Table Product Specifications of Incretin-Based Drugs
Figure Incretin-Based Drugs Report Years Considered
Figure Market Research Methodology
Figure Global Incretin-Based Drugs Consumption Growth Rate 2013-2023 (K Units)
Figure Global Incretin-Based Drugs Value Growth Rate 2013-2023 ($ Millions)
Table Incretin-Based Drugs Consumption CAGR by Region 2013-2023 ($ Millions)
Figure Product Picture of Glucagon-like peptide-1 receptor (GLP-1) agonists
Table Major Players of Glucagon-like peptide-1 receptor (GLP-1) agonists
Figure Product Picture of Dipeptidyl Peptidase-4 (DPP-4) inhibitors
Table Major Players of Dipeptidyl Peptidase-4 (DPP-4) inhibitors
Table Global Consumption Sales by Type (2013-2018)
Table Global Incretin-Based Drugs Consumption Market Share by Type (2013-2018)
Figure Global Incretin-Based Drugs Consumption Market Share by Type (2013-2018)
Table Global Incretin-Based Drugs Revenue by Type (2013-2018) ($ million)
Table Global Incretin-Based Drugs Value Market Share by Type (2013-2018) ($ Millions)
Figure Global Incretin-Based Drugs Value Market Share by Type (2013-2018)
Table Global Incretin-Based Drugs Sale Price by Type (2013-2018)
Figure Incretin-Based Drugs Consumed in Oral Drugs
Figure Global Incretin-Based Drugs Market: Oral Drugs (2013-2018) (K Units)
Figure Global Incretin-Based Drugs Market: Oral Drugs (2013-2018) ($ Millions)
Figure Global Oral Drugs YoY Growth ($ Millions)
Figure Incretin-Based Drugs Consumed in Injectable Drugs
Figure Global Incretin-Based Drugs Market: Injectable Drugs (2013-2018) (K Units)
Figure Global Incretin-Based Drugs Market: Injectable Drugs (2013-2018) ($ Millions)
Figure Global Injectable Drugs YoY Growth ($ Millions)
Table Global Consumption Sales by Application (2013-2018)
Table Global Incretin-Based Drugs Consumption Market Share by Application (2013-2018)
Figure Global Incretin-Based Drugs Consumption Market Share by Application (2013-2018)
Table Global Incretin-Based Drugs Value by Application (2013-2018)
Table Global Incretin-Based Drugs Value Market Share by Application (2013-2018)
Figure Global Incretin-Based Drugs Value Market Share by Application (2013-2018)
Table Global Incretin-Based Drugs Sale Price by Application (2013-2018)
Table Global Incretin-Based Drugs Sales by Players (2016-2018) (K Units)
Table Global Incretin-Based Drugs Sales Market Share by Players (2016-2018)
Figure Global Incretin-Based Drugs Sales Market Share by Players in 2016
Figure Global Incretin-Based Drugs Sales Market Share by Players in 2017
Table Global Incretin-Based Drugs Revenue by Players (2016-2018) ($ Millions)
Table Global Incretin-Based Drugs Revenue Market Share by Players (2016-2018)
Figure Global Incretin-Based Drugs Revenue Market Share by Players in 2016
Figure Global Incretin-Based Drugs Revenue Market Share by Players in 2017
Table Global Incretin-Based Drugs Sale Price by Players (2016-2018)
Figure Global Incretin-Based Drugs Sale Price by Players in 2017
Table Global Incretin-Based Drugs Manufacturing Base Distribution and Sales Area by Players
Table Players Incretin-Based Drugs Products Offered
Table Incretin-Based Drugs Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
Table Global Incretin-Based Drugs Consumption by Regions 2013-2018 (K Units)
Table Global Incretin-Based Drugs Consumption Market Share by Regions 2013-2018
Figure Global Incretin-Based Drugs Consumption Market Share by Regions 2013-2018
Table Global Incretin-Based Drugs Value by Regions 2013-2018 ($ Millions)
Table Global Incretin-Based Drugs Value Market Share by Regions 2013-2018
Figure Global Incretin-Based Drugs Value Market Share by Regions 2013-2018
Figure Americas Incretin-Based Drugs Consumption 2013-2018 (K Units)
Figure Americas Incretin-Based Drugs Value 2013-2018 ($ Millions)
Figure APAC Incretin-Based Drugs Consumption 2013-2018 (K Units)
Figure APAC Incretin-Based Drugs Value 2013-2018 ($ Millions)
Figure Europe Incretin-Based Drugs Consumption 2013-2018 (K Units)
Figure Europe Incretin-Based Drugs Value 2013-2018 ($ Millions)
Figure Middle East & Africa Incretin-Based Drugs Consumption 2013-2018 (K Units)
Figure Middle East & Africa Incretin-Based Drugs Value 2013-2018 ($ Millions)
Table Americas Incretin-Based Drugs Consumption by Countries (2013-2018) (K Units)
Table Americas Incretin-Based Drugs Consumption Market Share by Countries (2013-2018)
Figure Americas Incretin-Based Drugs Consumption Market Share by Countries in 2017
Table Americas Incretin-Based Drugs Value by Countries (2013-2018) ($ Millions)
Table Americas Incretin-Based Drugs Value Market Share by Countries (2013-2018)
Figure Americas Incretin-Based Drugs Value Market Share by Countries in 2017
Table Americas Incretin-Based Drugs Consumption by Type (2013-2018) (K Units)
Table Americas Incretin-Based Drugs Consumption Market Share by Type (2013-2018)
Figure Americas Incretin-Based Drugs Consumption Market Share by Type in 2017
Table Americas Incretin-Based Drugs Consumption by Application (2013-2018) (K Units)
Table Americas Incretin-Based Drugs Consumption Market Share by Application (2013-2018)
Figure Americas Incretin-Based Drugs Consumption Market Share by Application in 2017
Figure United States Incretin-Based Drugs Consumption Growth 2013-2018 (K Units)
Figure United States Incretin-Based Drugs Value Growth 2013-2018 ($ Millions)
Figure Canada Incretin-Based Drugs Consumption Growth 2013-2018 (K Units)
Figure Canada Incretin-Based Drugs Value Growth 2013-2018 ($ Millions)
Figure Mexico Incretin-Based Drugs Consumption Growth 2013-2018 (K Units)
Figure Mexico Incretin-Based Drugs Value Growth 2013-2018 ($ Millions)
Table APAC Incretin-Based Drugs Consumption by Countries (2013-2018) (K Units)
Table APAC Incretin-Based Drugs Consumption Market Share by Countries (2013-2018)
Figure APAC Incretin-Based Drugs Consumption Market Share by Countries in 2017
Table APAC Incretin-Based Drugs Value by Countries (2013-2018) ($ Millions)
Table APAC Incretin-Based Drugs Value Market Share by Countries (2013-2018)
Figure APAC Incretin-Based Drugs Value Market Share by Countries in 2017
Table APAC Incretin-Based Drugs Consumption by Type (2013-2018) (K Units)
Table APAC Incretin-Based Drugs Consumption Market Share by Type (2013-2018)
Figure APAC Incretin-Based Drugs Consumption Market Share by Type in 2017
Table APAC Incretin-Based Drugs Consumption by Application (2013-2018) (K Units)
Table APAC Incretin-Based Drugs Consumption Market Share by Application (2013-2018)
Figure APAC Incretin-Based Drugs Consumption Market Share by Application in 2017
Figure China Incretin-Based Drugs Consumption Growth 2013-2018 (K Units)
Figure China Incretin-Based Drugs Value Growth 2013-2018 ($ Millions)
Figure Japan Incretin-Based Drugs Consumption Growth 2013-2018 (K Units)
Figure Japan Incretin-Based Drugs Value Growth 2013-2018 ($ Millions)
Figure Korea Incretin-Based Drugs Consumption Growth 2013-2018 (K Units)
Figure Korea Incretin-Based Drugs Value Growth 2013-2018 ($ Millions)
Figure Southeast Asia Incretin-Based Drugs Consumption Growth 2013-2018 (K Units)
Figure Southeast Asia Incretin-Based Drugs Value Growth 2013-2018 ($ Millions)
Figure India Incretin-Based Drugs Consumption Growth 2013-2018 (K Units)
Figure India Incretin-Based Drugs Value Growth 2013-2018 ($ Millions)
Figure Australia Incretin-Based Drugs Consumption Growth 2013-2018 (K Units)
Figure Australia Incretin-Based Drugs Value Growth 2013-2018 ($ Millions)
Table Europe Incretin-Based Drugs Consumption by Countries (2013-2018) (K Units)
Table Europe Incretin-Based Drugs Consumption Market Share by Countries (2013-2018)
Figure Europe Incretin-Based Drugs Consumption Market Share by Countries in 2017
Table Europe Incretin-Based Drugs Value by Countries (2013-2018) ($ Millions)
Table Europe Incretin-Based Drugs Value Market Share by Countries (2013-2018)
Figure Europe Incretin-Based Drugs Value Market Share by Countries in 2017
Table Europe Incretin-Based Drugs Consumption by Type (2013-2018) (K Units)
Table Europe Incretin-Based Drugs Consumption Market Share by Type (2013-2018)
Figure Europe Incretin-Based Drugs Consumption Market Share by Type in 2017
Table Europe Incretin-Based Drugs Consumption by Application (2013-2018) (K Units)
Table Europe Incretin-Based Drugs Consumption Market Share by Application (2013-2018)
Figure Europe Incretin-Based Drugs Consumption Market Share by Application in 2017
Figure Germany Incretin-Based Drugs Consumption Growth 2013-2018 (K Units)
Figure Germany Incretin-Based Drugs Value Growth 2013-2018 ($ Millions)
Figure France Incretin-Based Drugs Consumption Growth 2013-2018 (K Units)
Figure France Incretin-Based Drugs Value Growth 2013-2018 ($ Millions)
Figure UK Incretin-Based Drugs Consumption Growth 2013-2018 (K Units)
Figure UK Incretin-Based Drugs Value Growth 2013-2018 ($ Millions)
Figure Italy Incretin-Based Drugs Consumption Growth 2013-2018 (K Units)
Figure Italy Incretin-Based Drugs Value Growth 2013-2018 ($ Millions)
Figure Russia Incretin-Based Drugs Consumption Growth 2013-2018 (K Units)
Figure Russia Incretin-Based Drugs Value Growth 2013-2018 ($ Millions)
Figure Spain Incretin-Based Drugs Consumption Growth 2013-2018 (K Units)
Figure Spain Incretin-Based Drugs Value Growth 2013-2018 ($ Millions)
Table Middle East & Africa Incretin-Based Drugs Consumption by Countries (2013-2018) (K Units)
Table Middle East & Africa Incretin-Based Drugs Consumption Market Share by Countries (2013-2018)
Figure Middle East & Africa Incretin-Based Drugs Consumption Market Share by Countries in 2017
Table Middle East & Africa Incretin-Based Drugs Value by Countries (2013-2018) ($ Millions)
Table Middle East & Africa Incretin-Based Drugs Value Market Share by Countries (2013-2018)
Figure Middle East & Africa Incretin-Based Drugs Value Market Share by Countries in 2017
Table Middle East & Africa Incretin-Based Drugs Consumption by Type (2013-2018) (K Units)
Table Middle East & Africa Incretin-Based Drugs Consumption Market Share by Type (2013-2018)
Figure Middle East & Africa Incretin-Based Drugs Consumption Market Share by Type in 2017
Table Middle East & Africa Incretin-Based Drugs Consumption by Application (2013-2018) (K Units)
Table Middle East & Africa Incretin-Based Drugs Consumption Market Share by Application (2013-2018)
Figure Middle East & Africa Incretin-Based Drugs Consumption Market Share by Application in 2017
Figure Egypt Incretin-Based Drugs Consumption Growth 2013-2018 (K Units)
Figure Egypt Incretin-Based Drugs Value Growth 2013-2018 ($ Millions)
Figure South Africa Incretin-Based Drugs Consumption Growth 2013-2018 (K Units)
Figure South Africa Incretin-Based Drugs Value Growth 2013-2018 ($ Millions)
Figure Israel Incretin-Based Drugs Consumption Growth 2013-2018 (K Units)
Figure Israel Incretin-Based Drugs Value Growth 2013-2018 ($ Millions)
Figure Turkey Incretin-Based Drugs Consumption Growth 2013-2018 (K Units)
Figure Turkey Incretin-Based Drugs Value Growth 2013-2018 ($ Millions)
Figure GCC Countries Incretin-Based Drugs Consumption Growth 2013-2018 (K Units)
Figure GCC Countries Incretin-Based Drugs Value Growth 2013-2018 ($ Millions)
Table Incretin-Based Drugs Distributors List
Table Incretin-Based Drugs Customer List
Figure Global Incretin-Based Drugs Consumption Growth Rate Forecast (2018-2023) (K Units)
Figure Global Incretin-Based Drugs Value Growth Rate Forecast (2018-2023) ($ Millions)
Table Global Incretin-Based Drugs Consumption Forecast by Countries (2018-2023) (K Units)
Table Global Incretin-Based Drugs Consumption Market Forecast by Regions
Table Global Incretin-Based Drugs Value Forecast by Countries (2018-2023) ($ Millions)
Table Global Incretin-Based Drugs Value Market Share Forecast by Regions
Figure Americas Incretin-Based Drugs Consumption 2018-2023 (K Units)
Figure Americas Incretin-Based Drugs Value 2018-2023 ($ Millions)
Figure APAC Incretin-Based Drugs Consumption 2018-2023 (K Units)
Figure APAC Incretin-Based Drugs Value 2018-2023 ($ Millions)
Figure Europe Incretin-Based Drugs Consumption 2018-2023 (K Units)
Figure Europe Incretin-Based Drugs Value 2018-2023 ($ Millions)
Figure Middle East & Africa Incretin-Based Drugs Consumption 2018-2023 (K Units)
Figure Middle East & Africa Incretin-Based Drugs Value 2018-2023 ($ Millions)
Figure United States Incretin-Based Drugs Consumption 2018-2023 (K Units)
Figure United States Incretin-Based Drugs Value 2018-2023 ($ Millions)
Figure Canada Incretin-Based Drugs Consumption 2018-2023 (K Units)
Figure Canada Incretin-Based Drugs Value 2018-2023 ($ Millions)
Figure Mexico Incretin-Based Drugs Consumption 2018-2023 (K Units)
Figure Mexico Incretin-Based Drugs Value 2018-2023 ($ Millions)
Figure Brazil Incretin-Based Drugs Consumption 2018-2023 (K Units)
Figure Brazil Incretin-Based Drugs Value 2018-2023 ($ Millions)
Figure China Incretin-Based Drugs Consumption 2018-2023 (K Units)
Figure China Incretin-Based Drugs Value 2018-2023 ($ Millions)
Figure Japan Incretin-Based Drugs Consumption 2018-2023 (K Units)
Figure Japan Incretin-Based Drugs Value 2018-2023 ($ Millions)
Figure Korea Incretin-Based Drugs Consumption 2018-2023 (K Units)
Figure Korea Incretin-Based Drugs Value 2018-2023 ($ Millions)
Figure Southeast Asia Incretin-Based Drugs Consumption 2018-2023 (K Units)
Figure Southeast Asia Incretin-Based Drugs Value 2018-2023 ($ Millions)
Figure India Incretin-Based Drugs Consumption 2018-2023 (K Units)
Figure India Incretin-Based Drugs Value 2018-2023 ($ Millions)
Figure Australia Incretin-Based Drugs Consumption 2018-2023 (K Units)
Figure Australia Incretin-Based Drugs Value 2018-2023 ($ Millions)
Figure Germany Incretin-Based Drugs Consumption 2018-2023 (K Units)
Figure Germany Incretin-Based Drugs Value 2018-2023 ($ Millions)
Figure France Incretin-Based Drugs Consumption 2018-2023 (K Units)
Figure France Incretin-Based Drugs Value 2018-2023 ($ Millions)
Figure UK Incretin-Based Drugs Consumption 2018-2023 (K Units)
Figure UK Incretin-Based Drugs Value 2018-2023 ($ Millions)
Figure Italy Incretin-Based Drugs Consumption 2018-2023 (K Units)
Figure Italy Incretin-Based Drugs Value 2018-2023 ($ Millions)
Figure Russia Incretin-Based Drugs Consumption 2018-2023 (K Units)
Figure Russia Incretin-Based Drugs Value 2018-2023 ($ Millions)
Figure Spain Incretin-Based Drugs Consumption 2018-2023 (K Units)
Figure Spain Incretin-Based Drugs Value 2018-2023 ($ Millions)
Figure Egypt Incretin-Based Drugs Consumption 2018-2023 (K Units)
Figure Egypt Incretin-Based Drugs Value 2018-2023 ($ Millions)
Figure South Africa Incretin-Based Drugs Consumption 2018-2023 (K Units)
Figure South Africa Incretin-Based Drugs Value 2018-2023 ($ Millions)
Figure Israel Incretin-Based Drugs Consumption 2018-2023 (K Units)
Figure Israel Incretin-Based Drugs Value 2018-2023 ($ Millions)
Figure Turkey Incretin-Based Drugs Consumption 2018-2023 (K Units)
Figure Turkey Incretin-Based Drugs Value 2018-2023 ($ Millions)
Figure GCC Countries Incretin-Based Drugs Consumption 2018-2023 (K Units)
Figure GCC Countries Incretin-Based Drugs Value 2018-2023 ($ Millions)
Table Global Incretin-Based Drugs Consumption Forecast by Type (2018-2023) (K Units)
Table Global Incretin-Based Drugs Consumption Market Share Forecast by Type (2018-2023)
Table Global Incretin-Based Drugs Value Forecast by Type (2018-2023) ($ Millions)
Table Global Incretin-Based Drugs Value Market Share Forecast by Type (2018-2023)
Table Global Incretin-Based Drugs Consumption Forecast by Application (2018-2023) (K Units)
Table Global Incretin-Based Drugs Consumption Market Share Forecast by Application (2018-2023)
Table Global Incretin-Based Drugs Value Forecast by Application (2018-2023) ($ Millions)
Table Global Incretin-Based Drugs Value Market Share Forecast by Application (2018-2023)
Table GlaxoSmithKline Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table GlaxoSmithKline Incretin-Based Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
Figure GlaxoSmithKline Incretin-Based Drugs Market Share (2016-2018)
Table Johnson & Johnson Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Johnson & Johnson Incretin-Based Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Johnson & Johnson Incretin-Based Drugs Market Share (2016-2018)
Table Merck & Co Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Merck & Co Incretin-Based Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Merck & Co Incretin-Based Drugs Market Share (2016-2018)
Table AstraZeneca Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table AstraZeneca Incretin-Based Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
Figure AstraZeneca Incretin-Based Drugs Market Share (2016-2018)
Table Novartis Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Novartis Incretin-Based Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Novartis Incretin-Based Drugs Market Share (2016-2018)
Table Eli Lilly and Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Eli Lilly and Company Incretin-Based Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Eli Lilly and Company Incretin-Based Drugs Market Share (2016-2018)
Table Boehringer Ingelheim Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Boehringer Ingelheim Incretin-Based Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Boehringer Ingelheim Incretin-Based Drugs Market Share (2016-2018)
Table Takeda Pharmaceutical Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Takeda Pharmaceutical Company Incretin-Based Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Takeda Pharmaceutical Company Incretin-Based Drugs Market Share (2016-2018)
Table Sanofi Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Sanofi Incretin-Based Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Sanofi Incretin-Based Drugs Market Share (2016-2018)
  • Global Alpha-Glucosidase Inhibitors Industry Market Research Report
    Published: 17-Oct-2019        Price: US 2960 Onwards        Pages: 110
    The Alpha-Glucosidase Inhibitors market revenue was xx.xx Million USD in 2014, grew to xx.xx Million USD in 2018, and will reach xx.xx Million USD in 2024, with a CAGR of x.x% during 2019-2024. Based on the Alpha-Glucosidase Inhibitors industrial chain, this report mainly elaborates the definition, types, applications and major players of Alpha-Glucosidase Inhibitors market in details. Deep analysis about market status (2014-2019), enterprise competition pattern, advantages and disadvantages of ......
  • Global Diabetes Drug Industry Market Research Report
    Published: 17-Oct-2019        Price: US 2960 Onwards        Pages: 117
    The Diabetes Drug market revenue was xx.xx Million USD in 2014, grew to xx.xx Million USD in 2018, and will reach xx.xx Million USD in 2024, with a CAGR of x.x% during 2019-2024. Based on the Diabetes Drug industrial chain, this report mainly elaborates the definition, types, applications and major players of Diabetes Drug market in details. Deep analysis about market status (2014-2019), enterprise competition pattern, advantages and disadvantages of enterprise products, industry development tre......
  • Global Insulin API Market Study 2016-2026, by Segment (Regular Human Insulin, Insulin Analogue) , by Market (Short Acting Insulin, Intermediate Acting Insulin,) , by Company (Novo Nordisk, Eli Lilly,)
    Published: 15-Oct-2019        Price: US 1800 Onwards        Pages: 53
    Summary The global Insulin API market will reach Volume Million USD in 2019 and with a CAGR xx% between 2020-2026. Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.): - Regular Human Insulin - Insulin Analogue Demand Coverage (Market Size & Forecast, Consumer Distribution): - Short Acting Insulin - Intermediate Acting Insulin - Long Acting Insulin - Pre-Mix Insulin ......
  • Global Human Insulin Market Study 2016-2026, by Segment (Short Acting Human Insulin, Intermediate Acting Human Insulin,) , by Market (Insulin Dependent Diabetes Mellitus, Non-Insulin Dependent Diabetes Mellitus) , by Company (Sanofi (France) , Eli Lilly and Company (U.S.) ,)
    Published: 13-Oct-2019        Price: US 1800 Onwards        Pages: 53
    Summary The global Human Insulin market will reach Volume Million USD in 2019 and with a CAGR xx% between 2020-2026. Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.): - Short Acting Human Insulin - Intermediate Acting Human Insulin - Premixed Human Insulin Demand Coverage (Market Size & Forecast, Consumer Distribution): - Insulin Dependent Diabetes Mellitus - Non-Insulin Dependent Di......
  • Global Incretin-Based Drugs Market Professional Survey Report 2019
    Published: 08-Oct-2019        Price: US 3500 Onwards        Pages: 102
    Incretins are gut derived hormones, released after the ingestion of food. Incretins are classified into glucagon-like peptide-1 (GLP-1) and gastric inhibitory peptide (GIP). Both the molecules are inactivated by enzyme Dipeptidyl Peptidase-4 (DPP-4). Oral traditional anti-diabetic drugs, often fail to maintain the desired normal level of glucose, especially in the postprandial condition. This has resulted in a strong need for better therapeutics such as incretin based drugs. ......
  • Global Human Insulin Market Professional Survey Report 2019
    Published: 04-Oct-2019        Price: US 3500 Onwards        Pages: 103
    Human insulin is the name which describes synthetic insulin which is laboratory grown to mimic the insulin in humans. In 2018, North America is estimated to dominate the global human insulin market. The Asia-Pacific market is poised to grow the fastest, during the forecast period, owing to growing diabetes prevalence in APAC (coupled with large diabetic & pre-diabetic patient population), strengthening distribution networks of global product manufacturers in the region, evolving regulator......
  • Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Professional Survey Report 2019
    Published: 04-Oct-2019        Price: US 3500 Onwards        Pages: 103
    Dipeptidyl peptidase 4 (DPP-4) inhibitors are a class of medicine that lower high blood glucose levels and are used in the treatment of type 2 diabetes. The global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. This report focuses on Dipeptidyl Peptidase-4 (DPP-4) Inhibitors volume and value at global level, regional level and company level. F......
  • Global Antidiabetics Market Professional Survey Report 2019
    Published: 30-Sep-2019        Price: US 3500 Onwards        Pages: 105
    Type 1 Diabetes and Type 2 Diabetes are common types of diabetes. Treatments include (1) agents that increase the amount of insulin secreted by the pancreas, (2) agents that increase the sensitivity of target organs to insulin, and (3) agents that decrease the rate at which glucose is absorbed from the gastrointestinal tract. The North American antidiabetics market held the largest market revenue share in 2013. High market penetration of modern insulin products such as long-acting, rapid ......
  • Global Lixisenatide Market Professional Survey Report 2019
    Published: 26-Sep-2019        Price: US 3500 Onwards        Pages: 107
    Lixisenatide is a once-daily injectable GLP-1 receptor agonist for the treatment of diabetes type II.  The growth of the global lixisenatide market is driven by increase in prevalence diabetes and surge in overweight populace. Moreover, unhealthy urban lifestyle and increase number of fast food eating populace susceptible to sudden weight gain are expected to boost the market growth. However, number of limited manufacturers and distribution channels is anticipated to imped......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs